FDA Office of Orphan Products Development logo
Orphan Products Natural History Studies Grants Program

Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases

Funds natural-history studies that improve preparedness for rare disease trial pathways.

OpenFDA Office of Orphan Products DevelopmentUnited States

The FDA OOPD Natural History Studies Grants Program, active since 2016, funds well-designed, protocol-driven natural history studies that address critical knowledge gaps in rare disease medical product development. The program operates under the R01 mechanism through NOFO RFA-FD-25-017. Studies must generate high-quality, interpretable data elements that remove major barriers to clinical trial rea…

Protocol-driven natural history studies that generate high-quality data to close knowledge gaps, enable clinical trial readiness, and advance medical product development for rare diseases and conditions.

CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Biennial
Next deadlineiThe next date applications are due. Rolling means you can apply any time.8 Feb 2028
Decision timeiTypical time from the deadline to the funder's decision.—
Project durationiHow long the funded work is expected to run.—
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.—

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see the timeline

Sign up free to see where teams trip up

Last verified: 22 Jul 2026Source: www.fda.gov